or Try an Advanced Search...

    Endocrine Disorders Stocks List

    Symbol Grade Name % Change
    SPRB F Spruce Biosciences, Inc. 0.89
    ENZ F Enzo Biochem, Inc. -2.27
    VKTX F Viking Therapeutics, Inc. 0.04
    PFE F Pfizer, Inc. -0.64
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Cancer Diabetes Disease Medication Medicine Metabolic Disease Obesity Acid Alcohol Alzheimer's Disease Anemia Animal Health Anti Infectives Antibodies Autoimmune Disease Biochemistry Biology Biotechnology Cachexia

    Related ETFs - A few ETFs which own one or more of the above listed Endocrine Disorders stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 13.4
    THNR F Amplify Weight Loss Drug & Treatment ETF 7.61
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 7.25
    OZEM F Roundhill GLP-1 & Weight Loss ETF 6.46
    FDL A First Trust Morningstar ETF 5.94
    View all Endocrine Disorders ETFs...
    Compare ETFs
    Compare FTXH to OZEM Compare THNR to FTXH Compare THNR to OZEM

        Endocrine Disorders Stocks Recent News

        Date Stock Title
        Nov 20 PFE CDC warns of an imminent spike in COVID, flu cases
        Nov 20 PFE 5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential
        Nov 20 VKTX Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
        Nov 20 PFE Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief
        Nov 20 PFE Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
        Nov 20 PFE Pfizer names head of oncology as new R&D chief
        Nov 20 PFE Pfizer Announces New Chief Scientific Officer and President, Research & Development
        Nov 20 PFE Pfizer names oncology head Chris Boshoff as R&D chief
        Nov 20 PFE Pfizer Names New R&D Chief
        Nov 20 PFE Pfizer, under pressure to change, names oncology head as new R&D chief
        Nov 20 PFE Is It Time to Sell Eli Lilly and Pfizer Stocks?
        Nov 20 PFE European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors
        Nov 20 PFE Flagship, Pfizer alliance yields two more startup deals
        Nov 19 PFE Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rules
        Nov 19 VKTX Viking phase 2b study of NASH candidate hits primary endpoint
        Nov 19 VKTX Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024
        Nov 19 PFE BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
        Nov 19 PFE ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
        Nov 19 PFE Pfizer (NYSE:PFE) stock falls 5.3% in past week as three-year earnings and shareholder returns continue downward trend
        Nov 19 PFE These 4 Price-to-Sales Stocks Can Supercharge Your Portfolio Growth
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Cancer Diabetes Disease Medication Medicine Metabolic Disease Obesity Acid Alcohol Alzheimer's Disease Anemia Animal Health Anti Infectives Antibodies Autoimmune Disease Biochemistry Biology Biotechnology Cachexia
        Endocrine Disorders

        Endocrine disorders are medical conditions that affect the endocrine system, which is a network of glands that produce hormones that regulate many bodily functions, including metabolism, growth and development, and sexual function. Common endocrine disorders include diabetes, thyroid disease, and adrenal gland disorders.

        Browse All Tags